Private Advisor Group’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History

Private Advisor Group’s Portfolio FOMX Stock Details FOMX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-10,000	Closed	-$33K	–	1688
2019 Q4	$33K	Hold	10,000	–	–	﹤0.01%	1598
2019 Q3	$30K	Buy	+10,000	New	+$28.1K	﹤0.01%	1623

Private Advisor Group's FOMX Position: Q1 2020 in Review

Private Advisor Group sold out of Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) in Q1 2020, closing a stake of 10,000 shares — an estimated $33K sold.

Private Advisor Group first reported a position in FOMX in Q3 2019 and held it in 2 quarters. The position peaked at $33K in Q4 2019. 3 funds tracked by Wall St. Rank hold FOMX as of Q1 2020.

Private Advisor Group reported no remaining Foamix Pharmaceuticals Ltd. Ordinary Shares position as of Q1 2020 after selling out during the quarter.
Private Advisor Group sold 10,000 Foamix Pharmaceuticals Ltd. Ordinary Shares shares in Q1 2020, an estimated $33K.
Private Advisor Group first reported a position in Foamix Pharmaceuticals Ltd. Ordinary Shares in Q3 2019 and held it in 2 quarters.
Private Advisor Group's Foamix Pharmaceuticals Ltd. Ordinary Shares position peaked at $33K in Q4 2019.
3 funds tracked by Wall St. Rank held Foamix Pharmaceuticals Ltd. Ordinary Shares as of Q1 2020.

Based on Private Advisor Group's 13F filing for Q1 2020, filed 12 May 2020.